MYC-high SCLC tumors have been shown to be sensitive to aurora kinase (AURK), ubiquitin specific peptidase 7 (USP7), mTOR, and dual PI3K/HDAC inhibition using in vivo models [17,147,148,151]. This evidence concerns the gene USP7 and small cell lung carcinoma.